Modlin Goes Micro at Fluidigm | GenomeWeb

Modlin Goes Micro at Fluidigm

Premium

There’s something about the teeny-tiny that fascinates Doug Modlin. The microfluidics expert and newly appointed vice president of R&D at Fluidigm recognized early on that downsizing (in its most positive meaning) was the way to go.

“I spent about half of my career in the semiconductor and computer industry,” Modlin says. “There’s a big carryover from the semiconductor world to access things that are small.”

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.